CYT387 treatment decreased the expression levels of both IKBKE and RRM2 in renal cancer cells (Figure 7A), and 5 μM CYT387 markedly inhibited renal cancer cell growth (Figure S2B). This evidence concerns the gene RRM2 and renal carcinoma.